Willingdon Wealth Management reduced its stake in Metlife Inc (NYSE:MET) by 98.0% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 1,103 shares of the financial services provider’s stock after selling 55,034 shares during the period. Willingdon Wealth Management’s holdings in Metlife were worth $47,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. GWM Advisors LLC lifted its stake in shares of Metlife by 389.0% in the 1st quarter. GWM Advisors LLC now owns 40,910 shares of the financial services provider’s stock valued at $242,000 after purchasing an additional 32,544 shares during the last quarter. Shell Asset Management Co. raised its position in Metlife by 2.4% in the 1st quarter. Shell Asset Management Co. now owns 270,808 shares of the financial services provider’s stock valued at $11,528,000 after purchasing an additional 6,319 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Metlife in the 1st quarter valued at about $2,360,000. Great West Life Assurance Co. Can raised its position in Metlife by 45.1% in the 1st quarter. Great West Life Assurance Co. Can now owns 1,103,117 shares of the financial services provider’s stock valued at $46,832,000 after purchasing an additional 342,919 shares in the last quarter. Finally, Dean Investment Associates LLC raised its position in Metlife by 4.2% in the 1st quarter. Dean Investment Associates LLC now owns 53,386 shares of the financial services provider’s stock valued at $2,273,000 after purchasing an additional 2,151 shares in the last quarter. Institutional investors own 77.09% of the company’s stock.

MET has been the topic of a number of analyst reports. Sandler O’Neill lowered Metlife from a “buy” rating to a “hold” rating and set a $50.00 price target on the stock. in a research report on Tuesday, March 19th. Argus reaffirmed a “buy” rating on shares of Metlife in a research report on Tuesday, February 12th. ValuEngine lowered Metlife from a “hold” rating to a “sell” rating in a research report on Wednesday, March 20th. Deutsche Bank increased their price target on Metlife from $46.00 to $47.00 and gave the company a “hold” rating in a research report on Friday, April 12th. Finally, UBS Group increased their price target on Metlife from $45.00 to $48.00 and gave the company a “neutral” rating in a research report on Tuesday, April 9th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and six have assigned a buy rating to the company’s stock. Metlife currently has an average rating of “Hold” and an average price target of $51.39.

Shares of MET traded up $0.58 during mid-day trading on Friday, reaching $47.83. The company’s stock had a trading volume of 3,469,503 shares, compared to its average volume of 5,498,404. Metlife Inc has a 12-month low of $37.76 and a 12-month high of $50.40. The company has a market cap of $45.46 billion, a P/E ratio of 8.87, a PEG ratio of 1.01 and a beta of 1.21. The company has a debt-to-equity ratio of 0.24, a quick ratio of 0.14 and a current ratio of 0.14.

Metlife (NYSE:MET) last released its quarterly earnings data on Wednesday, May 1st. The financial services provider reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.30 by $0.18. Metlife had a return on equity of 10.20% and a net margin of 7.56%. The business had revenue of $15.45 billion for the quarter, compared to the consensus estimate of $15.95 billion. During the same quarter in the prior year, the business posted $1.36 EPS. The business’s revenue for the quarter was up 2.0% on a year-over-year basis. As a group, analysts predict that Metlife Inc will post 5.61 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 13th. Stockholders of record on Tuesday, May 7th will be issued a $0.44 dividend. The ex-dividend date of this dividend is Monday, May 6th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 3.68%. This is an increase from Metlife’s previous quarterly dividend of $0.42. Metlife’s dividend payout ratio is presently 32.65%.

WARNING: “Willingdon Wealth Management Has $47,000 Holdings in Metlife Inc (MET)” was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://www.watchlistnews.com/willingdon-wealth-management-has-47000-holdings-in-metlife-inc-met/3022066.html.

Metlife Profile

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Featured Article: Why are trading ranges significant?

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.